Sort   by:  
 Page size 
UnknownRivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study.
Not available
S-EPMC9631568 | biostudies-literature
UnknownDMTs and Covid-19 severity in MS: a pooled analysis from Italy and France.
Not available
S-EPMC8351392 | biostudies-literature
UnknownThe effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis.
Not available
S-EPMC8652772 | biostudies-literature
UnknownDisease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
Not available
S-EPMC8013440 | biostudies-literature
UnknownThe ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis?
Not available
S-EPMC9755784 | biostudies-literature
UnknownChanges in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study.
Not available
S-EPMC7926077 | biostudies-literature
UnknownTocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Not available
S-EPMC7576974 | biostudies-literature
UnknownEfficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice.
Not available
S-EPMC2909229 | biostudies-literature
Sort   by:  
 Page size